APP and amyloidosis: Therefore, to determine if metabolic syndrome in mid-life is a risk factor for AD, we generated a comorbid AD mouse model by deleting Sirt3 gene globally in APP/PS1 mice, an Alzheimer’s transgenic mouse model with amyloid pathology.